Format

Send to

Choose Destination
See comment in PubMed Commons below
Eur J Pharmacol. 2014 Jan 15;723:330-8. doi: 10.1016/j.ejphar.2013.11.008. Epub 2013 Dec 3.

Pyrrolidine dithiocarbamate protects against scopolamine-induced cognitive impairment in rats.

Author information

1
Cairo University, Pharmacology & Toxicology Department, Faculty of Pharmacy, Egypt.
2
Cairo University, Pharmacology & Toxicology Department, Faculty of Pharmacy, Egypt. Electronic address: halafzaki@gmail.com.

Abstract

Alzheimer's disease (AD) is a chronic neurodegenerative disorder that leads to disturbances of cognitive functions. Although the primary cause of AD remains unclear, brain acetylcholine deficiency, oxidative stress and neuroinflammation may be considered the principal pathogenic factors. The present study was constructed to investigate the anti-amnestic effect of pyrrolidine dithiocarbamate (PDTC) on scopolamine-induced behavioral, neurochemical and biochemical changes in rats. PDTC (50 and 100mg/kg) and donepezil (2.5mg/kg) were orally administered for 14 successive days. Dementia was induced at the end of the treatment period by a single injection of scopolamine (20mg/kg; i.p.), and Y-maze test was conducted 30min thereafter. Rats were then sacrificed and homogenates of cortical and hippocampal tissues were used for the estimation of noradrenaline, dopamine, serotonin and heat shock protein 70 contents along with acetylcholinesterase activity. In addition, certain oxidative stress markers, pro-inflammatory and anti-inflammatory cytokines were assessed. Histological examination of cortical and hippocampal tissues was also performed. Scopolamine resulted in memory impairment that was coupled by alterations in the estimated neurotransmitters, heat shock protein 70, acetylcholinesterase activity, oxidative stress as well as inflammatory biomarkers. Histological analysis revealed serious damaging effects of scopolamine on the structure of cerebral cortex and hippocampus. Pretreatment of rats with PDTC in both doses mitigated scopolamine-induced behavioral, biochemical, neurochemical and histological changes in a manner comparable to donepezil. The observed anti-amnestic effect of PDTC makes it a promising candidate for clinical trials in patients with cognitive impairment.

KEYWORDS:

Acetylcholineesterase; Dementia; Heat shock protein 70; Neuroinflammation; Oxidative stress; Pyrrolidine dithiocarbamate

PMID:
24315930
DOI:
10.1016/j.ejphar.2013.11.008
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center